Rochester, NY, United States of America

Zhengdong Wang



 

Average Co-Inventor Count = 6.7

ph-index = 2

Forward Citations = 6(Granted Patents)


Company Filing History:


Years Active: 2013-2017

Loading Chart...
Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: Innovations of Zhengdong Wang in Synthetic Lung Surfactants

Introduction

Zhengdong Wang is a notable inventor based in Rochester, NY (US), recognized for his contributions to the field of synthetic lung surfactants. He holds three patents that focus on innovative compositions aimed at treating lung tissue dysfunction.

Latest Patents

Wang's latest patents include significant advancements in synthetic lung surfactant compositions. One of his inventions relates to synthetic lung surfactant compositions that incorporate a novel surface-active peptide and phospholipid derivatives. These compositions are designed to treat endogenous surfactant dysfunctional or deficient lung tissue and to deliver therapeutic agents effectively. Another patent focuses on synthetic lung surfactant compositions containing phospholipase-resistant phospho-glycerol and phospho-choline derivatives, along with surface-active proteins or peptides. This invention also aims to address the treatment of lung tissue deficiencies and the preparation of synthetic peptides for surfactant compositions.

Career Highlights

Zhengdong Wang has made significant strides in his career, working with esteemed institutions such as the University of Rochester and the Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center. His work has contributed to the advancement of medical treatments related to lung health.

Collaborations

Wang has collaborated with notable colleagues, including Robert H. Notter and Alan J. Waring, enhancing the impact of his research through teamwork and shared expertise.

Conclusion

Zhengdong Wang's innovative work in synthetic lung surfactants showcases his commitment to improving lung health through advanced medical solutions. His patents reflect a significant contribution to the field, promising better treatment options for patients with lung tissue deficiencies.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…